The management of enterocutaneous fistulae in Crohn's disease is still debated. Earlier studies' 2 recommended early surgical resection, while others have advocated medical management including total parenteral nutrition. -5 We have reviewed our experience of 39 patients (17 men) with 40 enterocutaneous fistulae seen in this unit between January 1970 and December 1980 to provide guidelines for the management of enterocutaneous fistulae in Crohn's disease. The mean age at diagnosis of fistula was 39.2 years (range years) with a mean interval of 9-5 years (range 0-33 years) from the initial diagnosis of Crohn's disease.
One patient who will not be considered further developed five separate enterocutaneous fistulae over a five year period arising from recurrent disease at separate sites in the gastrointestinal tract.
Methods

PATIENTS
The patients were divided into two groups. Group 1: no active disease. All 19 July 1982 otomy (n= 14) . It was often difficult to allocate patients to groups 2 (i) and 2 (ii) preoperatively as the diagnosis of intra-abdominal abscess was often only made at laparotomy (Table 1) .
CLINICAL PRESENTATION
The clinical details are summarised in Table 2 . Postoperative fistulae were commoner in older patients with a long history of Crohn's disease. The post-appendicectomy fistulae occurred in younger patients where the diagnosis of Crohn's disease had not been made preoperatively. None of these fistulae arose from the appendix stump.
The high incidence of malnutrition in patients with fistulae, active disease and associated sepsis (57%) was usually because of weight loss occurring after the fistula had developed (Table 2) .
ORIGIN OF THE FISTULAE
The majority of fistulae arose from the ileum ( Table 3 Hawker, Givel, Keighley, Alexander-Williams, and Allan 
Discussion
The principles of management of enterocutaneous fistulae in conditions other than Crohn's disease are well described./'6 These include the treatment of sepsis, nutritional and metabolic support, skin care, and surgical intervention to relieve distal obstruction.
The optimal management of fistulae in patients with Crohn's disease is debated. Individual series of patients with Crohn's disease usually include few patients with enterocutaneous fistulae,' 17 while series describing enterocutaneous fistulae only include a few patients with Crohn's disease." 12 Early operation with resection of the diseased bowel and any distal obstruction has been advocated' 2 though an aggressive surgical policy of resection in Crohn's disease could cause a short bowel syndrome. 18 Claims have been made that parenteral nutrition and 'bowel rest' can induce spontaneous closure in up to 50% of enterocutaneous fistulae3 5 but the validity of these claims has been challenged.'2 19 20 Because our analysis includes many referred patients we have been able to review the results of varied approaches to management. The presence of fistula is usually obvious clinically but can be readily confirmed with a fistulogram.
Postoperative fistulae (mainly anasomotic leaks) where there is no radiological evidence of recurrent or residual Crohn's disease or distal obstruction must be distinguished from fistulae associated with radiological evidence of recurrent or residual disease.
Postoperative fistulae will usually heal spontaneously with conservative measures alone. The inclusion of such patients in any study of 'specific' treatment could clearly produce apparently favourable but misleading results.
Attempts to close enterocutaneous fistulae secondary to residual or recurrent Crohn's disease which may be associated with local sepsis with specific medical treatment (salazopyrin, corticosteroids and azathioprine) or total parenteral nutrition in this series have been unsuccessful. These attempts have been associated with long delays before curative surgical resection has been undertaken.
Our results suggest that patients with enterocutaneous fistulae and active Crohn's disease can be 
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